Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Account Payables (2024 - 2025)

Beta Bionics' Change in Account Payables history spans 2 years, with the latest figure at $527000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 963.93% year-over-year to $527000.0; the TTM value through Dec 2025 reached $2.1 million, up 38.48%, while the annual FY2025 figure was $2.1 million, 38.48% up from the prior year.
  • Change in Account Payables for Q4 2025 was $527000.0 at Beta Bionics, down from $1.1 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.1 million in Q3 2025 and bottomed at -$97000.0 in Q1 2025.